Digital Pharma Innovation Week has ended
avatar for Robert Dudley, Ph.D.

Robert Dudley, Ph.D.

Clarus Therapeutics, Inc.
Chairman, CEO and President
Robert E. Dudley, Ph.D., has served as Chief Executive Officer, President and Chairman of the Board of Directors since founding Clarus Therapeutics in 2004. As the co-inventor of multiple formulations of testosterone replacement therapies, he is a leading voice in hypogonadism and men’s health. Most recently, he led the discovery, development, regulatory approval and launch of JATENZO, the first-and-only oral softgel testosterone replacement therapy.